Advanced search
Publication Cover
Cancer Investigation Volume 17, 1999 - Issue 8
Submit an article Journal homepage
51
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Cost Analysis of Second-Line Therapies for Platinum-Refractory Ovarian Cancer: Reimbursement Dilemmas for Medicare Patients

Original Article

Tammy J. Stinson The Lakeside VA Medical Center, Northwestern University Medical School, Chicago, Illinois
,
Elizabeth Calhoun Division of Hematology/Oncology, Northwestern University Medical School, Chicago, Illinois
,
Teresa Yang Division of Hematology/Oncology, Northwestern University Medical School, Chicago, Illinois
,
John R. Lurain Section of Gynecologic Oncology, Northwestern University Medical School, Chicago, Illinois
&
Charles L Bennett The Lakeside VA Medical Center, Northwestern University Medical School, Chicago, Illinois; Division of Hematology/Oncology, Northwestern University Medical School, Chicago, Illinois
Pages 559-565 | Published online: 11 Jun 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stephen RD Johnston. (2004) Ovarian Cancer: Review of the National Institute for Clinical Excellence (NICE) Guidance Recommendations. Cancer Investigation 22:5, pages 730-742.
Read now

Articles from other publishers (6)

Sharon Forrest, Mireille M Goetghebeur & Joel Hay. (2005) Medicare Coverage and Reimbursement of Outpatient Prescription Drugs in the US. Applied Health Economics and Health Policy 4:1, pages 9-14.
Crossref
Molly A. Brewer, Urs Utzinger, Jennifer K. Barton, James B. Hoying, Nathaniel D. Kirkpatrick, William R. Brands, John R. Davis, Katherine Hunt, Sally J. Stevens & Arthur F. Gmitro. (2016) Imaging of the Ovary. Technology in Cancer Research & Treatment 3:6, pages 617-627.
Crossref
D.H. Smith, J.R. Adams, S.R.D. Johnston, A. Gordon, M.F. Drummond & C.L. Bennett. (2002) A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK. Annals of Oncology 13:10, pages 1590-1597.
Crossref
Natasha B. LeighlFrances A. ShepherdRita KwongRonald L. BurkesRonald FeldPamela J. Goodwin. (2002) Economic Analysis of the TAX 317 Trial: Docetaxel Versus Best Supportive Care as Second-Line Therapy of Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 20:5, pages 1344-1352.
Crossref
Melissa Young & Greg L. Plosker. (2001) Paclitaxel. PharmacoEconomics 19:12, pages 1227-1259.
Crossref
Eric M. Horwitz & Gerald E. Hanks. (2000) Three-dimensional Conformal Radiation Therapy. Surgical Oncology Clinics of North America 9:3, pages 455-467.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.